Eastern Caribbean Health Outcomes Research Network (ECHORN) (ECHORN)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01994811 |
Recruitment Status :
Active, not recruiting
First Posted : November 26, 2013
Last Update Posted : January 20, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Cancer Cardiovascular Disease Diabetes |
Study Type : | Observational |
Actual Enrollment : | 3000 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Eastern Caribbean Health Outcomes Research Network (ECHORN) |
Actual Study Start Date : | April 2013 |
Actual Primary Completion Date : | June 14, 2018 |
Estimated Study Completion Date : | May 2021 |
- Diabetes [ Time Frame: 5 years ]Development of diabetes
- Cardiovascular disease [ Time Frame: 5 years ]Development of cardiovascular disease
- Cancer [ Time Frame: 5 years ]Development of cancer
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Greater than or equal to 18 years of age
- English or Spanish language speaking
- Resident of island at least 10 years
- Able to provide informed consent
- Non-institutionalized at the time of data collection
- Stable contact/residential information
- No plans to relocate from island within the next 5 years
Exclusion Criteria:
- Pregnant at time of recruitment

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01994811
Barbados | |
University of the West Indies, Cave Hill Campus | |
Bridgetown, Barbados, BB 11000 | |
Puerto Rico | |
University of Puerto Rico Medical Sciences Campus | |
San Juan, Puerto Rico, 00936-5067 | |
Trinidad and Tobago | |
University of the West Indies, St. Augustine Campus | |
St. Augustine, West Indies, Trinidad and Tobago | |
Virgin Islands (U.S.) | |
University of the Virgin Islands | |
Charlotte Amalie, Virgin Islands (U.S.), 00802-9990 |
Principal Investigator: | Marcella Nunez-Smith, MD, MHS | Yale School of Medicine |
Responsible Party: | Yale University |
ClinicalTrials.gov Identifier: | NCT01994811 |
Other Study ID Numbers: |
1108008959 5U24MD006938 ( U.S. NIH Grant/Contract ) |
First Posted: | November 26, 2013 Key Record Dates |
Last Update Posted: | January 20, 2021 |
Last Verified: | January 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | A Data Access and Scientific Review Committee (DASR), was been established to oversee requests for research collaboration (e.g. ancillary studies, secondary data analyses, etc.) to ensure they are within the scope of ECHORN's research mandate. Per the ECHORN Data Access Policy, data from ECHORN's research studies will be available to only internal ECHORN researchers for up to 3 years post data collection completion. Following that period, de-identified, limited ECHORN datasets will be made available for public access. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
cancer cardiovascular disease diabetes |
Cardiovascular Diseases |